AMAG Pharmaceuticals (AMAG) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 07/30/20
AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Australia and New ZealandGlobeNewsWire • 07/23/20
AMAG Announces Presentation of Ciraparantag Data at the International Society on Thrombosis and HaemostasisGlobeNewsWire • 07/12/20
Why Is AMAG Pharmaceuticals (AMAG) Up 6.8% Since Last Earnings Report?Zacks Investment Research • 06/10/20
AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 MillionGlobeNewsWire • 05/21/20
AMAG Pharma: Shedding Lackadaisical Segments And Management - Becoming A Focused, Undervalued Pure PlaySeeking Alpha • 05/11/20
AMAG Pharmaceuticals, Inc. (AMAG) CEO Scott Myers on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/11/20
AMAG Pharmaceuticals (AMAG) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/11/20
AMAG Pharmaceuticals (AMAG) Earnings Expected to Grow: What to Know Ahead of Q1 ReleaseZacks Investment Research • 04/28/20
AMAG Pharmaceuticals (AMAG) Down 21.5% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 04/03/20
AMAG Pharmaceuticals, Inc. (AMAG) CEO Bill Heiden on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/04/20
AMAG Pharmaceuticals (AMAG) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/04/20
AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/04/20